Andrew K. Balo - EVP Regulatory Strategy Clinic at Dexcom Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Regulatory Strategy Clinic
Stock Symbol
DXCM on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew K. Balo since 7/7/2023

Holdings reported by Andrew K. Balo for Dexcom Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 50,908 $6.29 M $123.63 Mar 10, 2023 Direct
Common Stock 30,212 $3.74 M $123.63 Mar 10, 2023 by Trust

Transactions reported by Andrew K. Balo for Dexcom Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership